It was reported that this patient presented to the hospital for asystole and syncope.Upon interrogation of this cardiac resynchronization therapy defibrillator (crt-d) it was found that there was loss of capture (loc) on the left ventricular (lv) lead as well as high capture thresholds on the right ventricular (rv) lead.Technical services (ts) analyzed presenting electrogram (egm) and discussed reprogramming options with boston scientific field sales representative.The lv lead is a non-boston scientific product.Threshold outputs were increased by programming.No additional adverse patient effects were reported.Currently, this crt-d system remains in service.According to additional information, this crt-d was explanted and replaced with a new device.No additional adverse patient effects were reported.As of today, this product has not been received by boston scientific for further evaluation.
|